Dr. McCullough joins Dr. Deb to discuss the cardiac risk factors of COVID illness and V-Injury. Dr. McCullough shares data on the cardiac inflammation seen with this disease and they discuss the new disease that is being seen as a result of this virus and post-vaccine injury.
Do not miss these highlights:
[04:32] The effectiveness of Oral and Nasal Virucidal Rinses and Washes
[05:11] The virus sets up camp in the nose in the mouth for about 3 or 4 days before it actually takes off as the infection so, there’s an opportunity to zap it
[06:45 ] In Finland, they have an approved antibody nasal spray against COVID-19
[07:47] August 30, 2021, CDC reports that 12,908 fully vaccinated Americans developed COVID-19 and there were deaths among these being reported
[10:17] The evidence seen in EKG and echocardiogram suggests that vaccine and myocarditis is far more serious than anything seen with natural infection
[12:54] The vaccine injuries are far less treatable across the cardiac, neurologic, and immunologic spectrum of disease
[13:16] Cardiac damage occurs far more in younger men than women after the second shot of the vaccine
[18:51] A discussion around the blood clotting issues with vaccines
[24:15] If there’s already injury in an organ system that is at risk for the vaccine, the consequences could be worse.
[27:23] A look at recommended early treatment programs and innovations against COVID
What if you could improve your health & increase your productivity? Find out how with the Vibrant Female Coaching Program at https://vibrantfemale.com/traning
About our Guest:
Dr. McCullough is board certified in internal medicine, cardiovascular diseases, and clinical lipidology. He cares for advanced patients with common medical problems including heart and kidney disease, lipid disorders, and diabetes. He has become an expert on COVID-19 illnesses and welcomes recovered patients into his practice. To inquire on Covid-19 related questions, email firstname.lastname@example.org
After receiving a bachelor’s degree from Baylor University, Dr. McCullough completed his medical degree as an Alpha Omega Alpha graduate from the University of Texas Southwestern Medical School. He went on to complete his internal medicine residency at the University of Washington, cardiology fellowship including service as Chief Fellow at William Beaumont Hospital, and master’s degree in public health at the University of Michigan.
Dr. McCullough has broadly published on a range of topics in medicine with > 1000 publications and > 600 citations in the National Library of Medicine. His works include the “Interface between Renal Disease and Cardiovascular Illness” in Braunwald’s Heart Disease Textbook. Dr. McCullough is a founder and current president of the Cardiorenal Society of America, an organization dedicated to bringing cardiologists and nephrologists together to work on the emerging problem of cardiorenal syndromes. His works have appeared in the New England Journal of Medicine, Journal of the American Medical
Association, Lancet, British Medical Journal and other top-tier journals worldwide. He is the editor-in-chief of Reviews in Cardiovascular Medicine and senior associate editor of the American Journal of Cardiology.
He serves on the editorial boards of multiple specialty journals. Dr. McCullough has made presentations on the advancement of medicine across the world and has been an invited lecturer at the New York Academy of Sciences, the National Institutes of Health, U.S. Food and Drug Administration (FDA), and the European Medicines Agency. He has served as member or chair of data safety monitoring boards of 24 randomized clinical trials.
Since the outset of the pandemic, Dr. McCullough has been a leader in the medical response to the COVID-19 disaster and has published “Pathophysiological Basis and Rationale for Early Outpatient Treatment of SARS-CoV-2 (COVID-19) Infection” the first synthesis of sequenced multidrug treatment of ambulatory patients infected with SARS-CoV-2 in the American Journal of Medicine and subsequently updated in Reviews in Cardiovascular Medicine. He has 35 peer-reviewed publications on the infection and has commented extensively on the medical response to the COVID-19 crisis in TheHill. On November 19, 2020, Dr. McCullough testified in the US Senate Committee on Homeland Security and Governmental Affairs concerning early ambulatory treatment of high-risk patients with COVID-19. Dr. McCullough is a COVID-19 survivor himself and welcomes post-COVID-19 patients into his practice and will help them through the range of post-infection complications.